W. Hoffman

发表

Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor.

C. Natanson, S. Banks, P. Eichacker, 1992, The American review of respiratory disease.

Septic shock: the cardiovascular abnormality and therapy.

C. Natanson, J. Parrillo, W. Hoffman, 1989, Journal of cardiothoracic anesthesia.

Antibiotics versus cardiovascular support in a canine model of human septic shock.

C. Natanson, S. Banks, R. Danner, 1990, The American journal of physiology.

Noninvasive cardiac output monitoring.

W. Hoffman, M. Popovich, 1997, Critical care medicine.

Reduced Argatroban Doses After Coronary Artery Bypass Graft Surgery

W. Hoffman, D. McCollum, M. J. Hursting, 2008, The Annals of pharmacotherapy.

Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.

D. Torchiana, S. Foo, R. Yeh, 2007, The Annals of thoracic surgery.

The Role of Endotoxin in Bacterial Septic Shock

C. Natanson, W. Hoffman, 1993 .

Endotoxin in Septic Shock

C. Natanson, W. Hoffman, 1993, Anesthesia and analgesia.

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure

C. Natanson, L. Cork, P. Eichacker, 1994, The Journal of experimental medicine.

Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction.

C. Natanson, S. Banks, J. Parrillo, 1992, The American journal of physiology.

Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock.

S. Banks, R. Rothlein, R. Danner, 1993, Journal of applied physiology.

Looking back on HA-1A.

C. Natanson, W. Hoffman, Z. Quezado, 1994, Archives of internal medicine.

Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.

C. Natanson, S. Banks, R. Danner, 1995, Journal of the American College of Surgeons.

TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis.

C. Natanson, S. Banks, P. Eichacker, 1991, Journal of applied physiology.

Plasma exchange does not improve survival in a canine model of human septic shock

C. Natanson, S. Banks, J. Parrillo, 1993, Transfusion.

Pathogenic effects of endotoxin.

W. Hoffman, J. Zivot, 1995, New horizons.

Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery*

Uwe Siebert, John B. Newell, Saif Anwaruddin, 2004, Critical care medicine.

Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock

C. Natanson, S. Banks, R. Danner, 1996, Infection and immunity.

Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis.

C. Natanson, S. Banks, P. Eichacker, 1994, Journal of applied physiology.

Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs.

C. Natanson, S. Banks, J. Cobb, 1995, The American journal of physiology.

Acute hemorrhage in dogs: construction and validation of models to quantify blood loss.

C. Natanson, S. Banks, P. Eichacker, 1993, Journal of applied physiology.

LACK OF PROTECTION BY Nw-METHYL-L-ARGININE (NMA), A NITRIC OXIDE SYNTHASE INHIBITOR, IN ENDOTOXIN (LPS)-CHALLENGED CANINES

C. Natanson, S. Banks, J. Cobb, 1993 .

Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period

R. Yeh, W. Hoffman, I. Jang, 2010, Journal of Thrombosis and Thrombolysis.

Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols*

A. Schechter, C. Natanson, S. Banks, 2007, Critical care medicine.

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

C. Natanson, S. Banks, J. Parrillo, 1989, The Journal of experimental medicine.

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin

C. Natanson, S. Banks, J. Cobb, 1992, The Journal of experimental medicine.

Brief Clinical ReportsEmphysematous gastritis

N. Ratliff, C. Bashour, W. Hoffman, 1998 .

Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide.

C. Natanson, S. Banks, R. Danner, 1994, The Journal of infectious diseases.

Therapeutic trial of lipid X in a canine model of septic shock.

C. Natanson, M. Doerfler, J. Parrillo, 1993, The Journal of infectious diseases.

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

D. Alling, C. Natanson, S. Banks, 1993, JAMA.

Serial measures of total body oxygen consumption in an awake canine model of septic shock.

C. Natanson, S. Banks, R. Danner, 1996, American journal of respiratory and critical care medicine.

Increasing doses of pentoxifylline as a continuous infusion in canine septic shock.

C. Natanson, S. Banks, R. Danner, 1999, The Journal of pharmacology and experimental therapeutics.

Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis.

C. Natanson, S. Banks, J. Parrillo, 1995, The American journal of physiology.

Factors that determine the hemodynamic response to inhalation anesthetics.

D. Alling, C. Natanson, S. Banks, 1991, Journal of applied physiology.

Human and Canine Septic Shock: Studies of Cardiovascular Abnormality, Mediators, and Therapies

C. Natanson, W. Hoffman, 1990 .

Participation of the atrial components of a dual-chamber cardiac pacemaker during ventricular pacing.

W. Hoffman, T. Alston, 2005, Journal of cardiothoracic and vascular anesthesia.

HEMODYNAMIC EFFECTS OF TUMOR NECROSIS FACTOR (TNF) INFUSIONS IN CONSCIOUS DOGS

C. Natanson, S. Banks, J. Parrillo, 1988 .

ANTIBIOTICS, FLUIDS AND DOPAMINE IN A LETHAL CANINE MODEL OF SEPTIC SHOCK (SS): EFFECTS ON SURVIVAL

C. Natanson, S. Banks, M. Doerfler, 1988 .